Purpose Platinum-based doublet chemotherapy may be the treatment of preference for
Purpose Platinum-based doublet chemotherapy may be the treatment of preference for individuals with non-small cell lung cancer (NSCLC); nevertheless, the role of the platinum-based doublet as second-line therapy after failing of the epidermal growth element receptor (EGFR) tyrosine kinase inhibitor (TKI) for NSCLC individuals has not however been elucidated. than that of individuals finding a … [Read more…]